Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GB Sciences Inc GBLX

Healthcare
GB Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company. It creates patented, disease-targeted formulations of cannabis and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. (GBSGB). The primary focus for the development of its lead program has been in evaluating suitable... see more

Recent & Breaking News (GREY:GBLX)

GB Sciences and University of Athens, Greece, Embark on Next-Level Drug Discovery Examining Cannabis-Based, Disease-Modifying Compounds

PR Newswire October 3, 2018

GB Sciences' Drug Development Program Benefits from Establishment of Clear Pathway for Cannabis-Based Drug Approvals and Commercialization

PR Newswire October 2, 2018

Catalent Selected to Provide Oral Delivery Systems for GB Sciences' Proprietary Parkinson's Disease Therapies

PR Newswire September 26, 2018

Jobs and Salaries in the Legal Cannabis Industry Continues to Grow

PR Newswire September 25, 2018

GB Sciences Granted a Recreational Production License for the Manufacture of Oils, Edibles, Vape Products, and Nutraceuticals

PR Newswire September 25, 2018

GB Sciences Hosts Cutting-Edge Cannabis Symposium "Innovation in Medical Cannabis Therapies"

PR Newswire September 20, 2018

GB Sciences' Dr. Andrea Small-Howard, Chief Science Officer, Will Be Moderating a Panel Discussion in "Cannabis Is Medicine" at the "State of Cannabis" Conference on the Queen Mary

PR Newswire September 18, 2018

Growing Need for Medical and Recreational Cannabis Looks to Continue Globally

PR Newswire September 17, 2018

Data Projects the Canadian Cannabis Market to be Worth Over USD 5 Billion in 2018

PR Newswire August 30, 2018

The State of Louisiana Pharmacy Board Has Selected Nine Initial Pharmacies to Dispense Medical Cannabis Formulations Through the GB Sciences and LSU Agriculture Center Partnership

PR Newswire August 23, 2018

GB Sciences and Louisiana State University Agricultural Center Begins Cultivation of Their First Cannabis Crop

PR Newswire August 21, 2018

Cannabis Market Growth Outpaces Estimates as Global Momentum Grows

PR Newswire August 20, 2018

GB Sciences reports first quarter revenue of $1.3 million with gross profit of $700 thousand compared to revenue of $69,100 for same period last year

GlobeNewswire August 15, 2018

Legal Cannabis Market is Growing More Competitive as Demand Grows

PR Newswire August 13, 2018

Michigan State University's Dr. Norbert Kaminski Begins Pre-Clinical Study of GB Sciences' Neuroprotective Cannabis Compounds For Parkinson's Disease

PR Newswire August 6, 2018

GB Sciences Co-Authors a Peer Reviewed Article Published in the Journal of the American Heart Association Titled: "Cannabinoids, The Heart of the Matter"

PR Newswire August 2, 2018

Data Points to the Usage of Legal Cannabis Is on the Rise

PR Newswire July 31, 2018

GB Sciences Strengthen Their Current and Future Compliance Programs by Building A Relationship with Adherence Compliance

GlobeNewswire July 31, 2018

GB Sciences Partners with the Colorado Hemp Project to Cultivate and Extract Full Spectrum Hemp Oil from Proprietary Hemp Strains to Open a New Revenue Stream in the Rapidly Growing Hemp Market

PR Newswire July 16, 2018

Data Projects That Nationwide Cannabis Retail Sales to Surpass USD 20 Billion by 2022

PR Newswire July 11, 2018